The nanoscale in pulmonary delivery. Part 2: formulation platforms.

The nanoscale in pulmonary delivery. Part 2: formulation platforms.

Item
http://www.wikidata.org/entity/Q36985898
Advances in device and formulation technologies for pulmonary drug delivery.Nanomedicine for the management of lung and blood diseases.Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?Core-shell nanocarriers for cancer therapy. Part I: biologically oriented design rules.Sustained inhibition of IL-6 and IL-8 expression by decoy ODN to NF-κB delivered through respirable large porous particles in LPS-stimulated cystic fibrosis bronchial cells.Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunitiesLost in translation: what is stopping inhaled nanomedicines from realizing their potential?Towards the Identification of an In Vitro Tool for Assessing the Biological Behavior of Aerosol Supplied Nanomaterials.Evaluating the Controlled Release Properties of Inhaled Nanoparticles Using Isolated, Perfused, and Ventilated Lung ModelsFormation of Protein Nano-Matrix Particles with Controlled Surface Architecture for Respiratory Drug Delivery
P2860

The nanoscale in pulmonary delivery. Part 2: formulation platforms.

Item
http://www.wikidata.org/entity/Q36985898
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The nanoscale in pulmonary delivery. Part 2: formulation platforms.
@en
type
label
The nanoscale in pulmonary delivery. Part 2: formulation platforms.
@en
prefLabel
The nanoscale in pulmonary delivery. Part 2: formulation platforms.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
The nanoscale in pulmonary delivery. Part 2: formulation platforms.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698